who should take semaglutide for weight loss FDA Approves Oral Semaglutide: First GLP-1 Pill Semaglutide GLP-1 Medical Weight Loss

The FDA Wegovy prescribing information describes semaglutide as used with reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in eligible adults

FDA delayed that application in March after it issued a refusal to file letter

Ready to Explore the Next Generation of Metabolic Treatment

Some nausea in week one is expected and usually resolves as your body adapts

As with any research compound, careful protocol design, observation, and adherence to ethical guidelines are paramount

Ozempic, Wegovy, Victoza, and Saxenda are registered trademarks of Novo Nordisk A/S